type here...

CATEGORIES

Breaking Research

LATEST

123Page 2 of 3

TRENDING

EDITORS CHOICE

Achieve Life Sciences Announces Statistically Significant Smoking Cessation Results in Phase 3 ORCA-2 Clinical Trial of Cytisinicline in Adult Smokers

Medika Life -
Clinical results in primary and secondary endpoints for 6- and 12-week experimental smoking cessation treatment reported by company sponsor.

The Scary Reality of Modern Healthcare

Charles Black -
We often don’t know what we are doing, but we can’t stop. Science and research never stop.

Fighting Age-Related Macular Degeneration

Michael Hunter, MD -
A new study confirms supplements slow macular degeneration, an eye condition that can cause blindness.

Perhaps, A Braver New World

John Nosta -
The drip, drip, drip of innovation might just be a myth. Change commonly occurs as a punctuated reality that’s a function of converging events...

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

© Medika Life 2020 - 2022

Compliance

CORPORATE & MEDIA

Popular categories